PYC 0.00% 14.5¢ pyc therapeutics limited

a rare beast.

  1. 10,009 Posts.
    just watching the other companies in this sector highlights what a rare beast this one is. most are trying to get through long expensive trials, or looking for partners to assist moving forawd.

    whilst many have bright prospects the punters are a bit gun shy of their prospects. PXS and CXS have given a few thrills. so has MSB .

    PYC has a unique business model, with so much interest from big pharma for their Library of Phylomers the financial rewards are built into the business model much earlier.

    The risks are reduced. The market is waking up to PYC's approach.

    This is a safe way to get BIO exposure whilst maintaining the potential upside.

    Once the three deals which have been flagged by the company have been formally signed we will be abble to put a more solid valuation on the is little company. that valuation should be on an international basis.

watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Mkt cap ! $459.7M
Open High Low Value Volume
14.5¢ 14.5¢ 14.5¢ $19.08K 131.6K

Buyers (Bids)

No. Vol. Price($)
5 479054 14.0¢

Sellers (Offers)

Price($) Vol. No.
14.5¢ 101910 3
View Market Depth
Last trade - 10.51am 09/03/2021 (20 minute delay) ?
0.000 ( 3.45 %)
Open High Low Volume
14.0¢ 14.5¢ 14.0¢ 242850
Last updated 11.45am 09/03/2021 (live) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.